ATACHAtrial Tachycardia
References in periodicals archive ?
ATACH is a National Institutes of Health-funded study.
The results of the ATACH trial provide new encouraging data on low rates of treatment failure, neurological deteriorations within 24 hours, and serious adverse events within 72 hours of stroke onset.
Study Coordinator Jill Novitzke RN from the Zeenat Qureshi Stroke Research Center commented that the ATACH study establishes the foundation for larger studies in the future.